| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NGM | NGM BIOPHARMACEUTICALS INC | Chief Executive Officer, Director | $0 | Apr 5, 2024 | ||
| SRZN, SRZNW | Surrozen, Inc./DE | Director | Jun 5, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|